Is Sleep Number Corp. overvalued or undervalued?
As of July 25, 2018, Sleep Number Corp. is considered risky due to its negative price-to-book value of -0.47, high EV to EBITDA ratio of 9.53, and significant underperformance with a one-year return of -54.77%, contrasting sharply with healthier valuations of peers like Ethan Allen and Arhaus.
As of 25 July 2018, the valuation grade for Sleep Number Corp. has moved from fair to risky, indicating a significant deterioration in its financial outlook. The company appears to be overvalued given its negative price-to-book value of -0.47 and a high EV to EBITDA ratio of 9.53, which suggests that investors are paying a premium relative to its earnings potential. Additionally, the EV to Sales ratio of 0.53 further reinforces the notion that the market may be overestimating the company's value.When compared to peers, Sleep Number Corp. shows a stark contrast with Ethan Allen Interiors, Inc., which has a P/E ratio of 28.41 and an EV to EBITDA of 17.96, indicating a much healthier valuation profile. Similarly, Arhaus, Inc. has a P/E ratio of 22.58 and an EV to EBITDA of 8.19, both of which are significantly better than Sleep Number's metrics. The company's stock has underperformed dramatically, with a one-year return of -54.77% compared to the S&P 500's 17.14%, which highlights the challenges it faces in the current market environment.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
